Michael W. Pill
Impact in
-
- Multiple Sclerosis Research Studies
-
- Allergic Rhinitis and Sensitization
Papers in
-
- Multiple Sclerosis Research Studies 5
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- Christina Caon (1 shared paper)Christine Nichols (1 shared paper)Mark I. Friedman (1 shared paper)Joseph Menzin (1 shared paper)Leigh Ann White (1 shared paper)Eli O. Meltzer (1 shared paper)Doral Fredericks (1 shared paper)James C. Norton (1 shared paper)
- Journals
- Journal of Managed Care & Specialty Pharmacy (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)Journal of Medical Economics (1 paper)PubMed (3 papers)Journal of Managed Care Pharmacy (4 papers)
- Partner nations
- United StatesSpain
In The Last Decade
Michael W. Pill
10 papers receiving 513 citations
Peers
Comparison fields: 5 of 63
- Pathology and Forensic Medicine 274
- Immunology and Allergy 34
- Neurology 57
- Rheumatology 50
- Otorhinolaryngology 14
Countries citing papers authored by Michael W. Pill
This map shows the geographic impact of Michael W. Pill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Pill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Pill more than expected).
Fields of papers citing papers by Michael W. Pill
This network shows the impact of papers produced by Michael W. Pill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Pill. The network helps show where Michael W. Pill may publish in the future.
Co-authors
The 17 scholars most cited alongside Michael W. Pill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 180 | |
| 2 | 2007 | 91 | |
| 3 | 2004 | 67 | |
| 4 | Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden. | 2017 | 56 |
| 5 | 2013 | 40 | |
| 6 | 1997 | 34 | |
| 7 | A claims-based view of health care charges and utilization for commercially insured patients with osteoarthritis. | 2009 | 30 |
| 8 | 2013 | 17 | |
| 9 | 2016 | 14 | |
| 10 | Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis. | 2010 | 7 |
About Michael W. Pill
Michael W. Pill is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health, Molecular Biology, Pharmacology and Neurology, having authored 10 papers that have together received 536 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (5 papers), Acute Lymphoblastic Leukemia research (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper), Nephrotoxicity and Medicinal Plants (1 paper), Neurological disorders and treatments (1 paper), Polyomavirus and related diseases (1 paper) and Drug-Induced Adverse Reactions (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (274 citations), Immunology and Allergy (34 citations), Neurology (57 citations), Rheumatology (50 citations) and Otorhinolaryngology (14 citations). Michael W. Pill has collaborated with scholars based in United States and Spain. Frequent co-authors include Christina Caon, Christine Nichols, Mark I. Friedman, Joseph Menzin, Leigh Ann White, Eli O. Meltzer, Doral Fredericks, James C. Norton, Grant H. Skrepnek and Ajay Singh. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Medical Economics, PubMed and Journal of Managed Care Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.